FCGRT and chronic inflammatory demyelinating polyradiculoneuropathy: The pronounced reduction of serum immunoglobulins by FcRn modulation is a novel emerging therapeutic target, which is currently under investigation for CIDP, with very promising preliminary results of clinical studies.